Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-25-074700
Filing Date
2025-04-07
Accepted
2025-04-07 16:31:22
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A d820895ddefa14a.htm DEFA14A 24480
  Complete submission text file 0001193125-25-074700.txt   25687
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
ZEVRA THERAPEUTICS, INC. (Filer) CIK: 0001434647 (see all company filings)

EIN.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36913 | Film No.: 25818589
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)